EMA 'Confident' Of New COVID-19 Vaccine Approvals By Year End
The European drugs regulator has given an overview of progress with the assessment of new vaccine candidates, additional and booster vaccines, and the use of vaccines in younger age groups.
You may also be interested in...
Celltrion continues to eye further markets for its CT-P59 regdanvimab monoclonal antibody treatment for COVID-19, especially in the EU, after winning final approval from the Korean Ministry of Food and Drug Safety.
AstraZeneca's Vaxzevria and Pfizer/BioNTech's vaccine can be used as "booster" vaccines in the UK, pending advice on a possible vaccination campaign from the government's advisory committee.
The EU’s pharmacovigilance committee has recommended safety updates for two COVID-19 vaccines, and is keeping its eye on a range of possible side-effects with all four authorized products.